Invesco’s Genesis Healthcare, Inc. GEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-217,504
Closed -$357K 3772
2019
Q4
$357K Buy
217,504
+26,596
+14% +$39.9K ﹤0.01% 3374
2019
Q3
$212K Buy
190,908
+3,970
+2% +$4.59K ﹤0.01% 3538
2019
Q2
$232K Sell
186,938
-6,446
-3% -$8.21K ﹤0.01% 3578
2019
Q1
$278K Buy
+193,384
New +$287K ﹤0.01% 3515
2018
Q1
Sell
-142,133
Closed -$108K 3801
2017
Q4
$108K Buy
142,133
+5,075
+4% +$4.54K ﹤0.01% 3603
2017
Q3
$159K Buy
137,058
+7,999
+6% +$10.1K ﹤0.01% 3579
2017
Q2
$225K Buy
129,059
+1,605
+1% +$3.41K ﹤0.01% 3564
2017
Q1
$336K Buy
+127,454
New +$458K ﹤0.01% 3473
2016
Q2
Sell
-1,983,591
Closed -$4.6M 3748
2016
Q1
$4.6M Sell
1,983,591
-227,808
-10% -$515K ﹤0.01% 1934
2015
Q4
$7.67M Buy
2,211,399
+24,888
+1% +$119K ﹤0.01% 1603
2015
Q3
$13.4M Buy
2,186,511
+1,398
+0.1% +$9.48K 0.01% 1323
2015
Q2
$14.4M Sell
2,185,113
-44,167
-2% -$298K 0.01% 1370
2015
Q1
$15.9M Buy
+2,229,280
New +$16.8M 0.01% 1318

Other funds holding GEN

Invesco's GEN Position: Q1 2020 in Review

Invesco sold out of Genesis Healthcare, Inc. (GEN) in Q1 2020, closing a stake of 217,504 shares — an estimated $357K sold.

Invesco first reported a position in GEN in Q1 2015 and held it in 13 quarters. The position peaked at $15.9M in Q1 2015. 67 funds tracked by Wall St. Rank hold GEN as of Q1 2020.

  • Invesco reported no remaining Genesis Healthcare, Inc. position as of Q1 2020 after selling out during the quarter.
  • Invesco sold 217,504 Genesis Healthcare, Inc. shares in Q1 2020, an estimated $357K.
  • Invesco first reported a position in Genesis Healthcare, Inc. in Q1 2015 and held it in 13 quarters.
  • Invesco's Genesis Healthcare, Inc. position peaked at $15.9M in Q1 2015.
  • 67 funds tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q1 2020.

Based on Invesco's 13F filing for Q1 2020, filed 15 May 2020.